Anchor Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Anchor Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-312	Closed	-$8.68K	–	1048
2025 Q3	$8.68K	Hold	312	–	–	﹤0.01%	834
2025 Q2	$7.61K	Hold	312	–	–	﹤0.01%	842
2025 Q1	$6.49K	Hold	312	–	–	﹤0.01%	855
2024 Q4	$7.36K	Sell	312 -20	-6%	-$492	﹤0.01%	841
2024 Q3	$8.51K	Buy	332 +28	+9%	+$713	﹤0.01%	809
2024 Q2	$7.15K	Buy	304 +37	+14%	+$934	﹤0.01%	802
2024 Q1	$7.69K	Buy	267 +17	+7%	+$511	﹤0.01%	822
2023 Q4	$8.22K	Buy	250 +50	+25%	+$1.36K	﹤0.01%	775
2023 Q3	$5.58K	Hold	200	–	–	﹤0.01%	820
2023 Q2	$6.83K	Buy	200 +25	+14%	+$786	﹤0.01%	793
2023 Q1	$5.28K	Buy	175 +42	+32%	+$1.3K	﹤0.01%	828
2022 Q4	$3.77K	Hold	133	–	–	﹤0.01%	827
2022 Q3	$4.39K	Hold	133	–	–	﹤0.01%	814
2022 Q2	$4.2K	Buy	133 +25	+23%	+$874	﹤0.01%	833
2022 Q1	$4.98K	Sell	108 -384	-78%	-$18.3K	﹤0.01%	845
2021 Q4	$30.1K	Buy	+492	New	+$34K	﹤0.01%	633

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Anchor Investment Management's ARKG Position: Q4 2025 in Review

Anchor Investment Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 312 shares — an estimated $8.68K sold.

Anchor Investment Management first reported a position in ARKG in Q4 2021 and held it in 16 quarters. The position peaked at $30.1K in Q4 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Anchor Investment Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
Anchor Investment Management sold 312 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $8.68K.
Anchor Investment Management first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 16 quarters.
Anchor Investment Management's ARK Genomic Revolution ETF position peaked at $30.1K in Q4 2021.
239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Anchor Investment Management's 13F filing for Q4 2025, filed 26 Feb 2026.